| 000 | 01753 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518035341.0 | ||
| 264 | 0 | _c20190513 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a2041-1723 | ||
| 024 | 7 |
_a10.1038/s41467-019-09809-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTian, Weihua | |
| 245 | 0 | 0 |
_aThe glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells. _h[electronic resource] |
| 260 |
_bNature communications _c04 2019 |
||
| 300 |
_a1785 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFabry Disease _xdrug therapy |
| 650 | 0 | 4 | _aGlycosylation |
| 650 | 0 | 4 |
_aLysosomes _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aalpha-Galactosidase _xtherapeutic use |
| 700 | 1 | _aYe, Zilu | |
| 700 | 1 | _aWang, Shengjun | |
| 700 | 1 | _aSchulz, Morten Alder | |
| 700 | 1 | _aVan Coillie, Julie | |
| 700 | 1 | _aSun, Lingbo | |
| 700 | 1 | _aChen, Yen-Hsi | |
| 700 | 1 | _aNarimatsu, Yoshiki | |
| 700 | 1 | _aHansen, Lars | |
| 700 | 1 | _aKristensen, Claus | |
| 700 | 1 | _aMandel, Ulla | |
| 700 | 1 | _aBennett, Eric Paul | |
| 700 | 1 | _aJabbarzadeh-Tabrizi, Siamak | |
| 700 | 1 | _aSchiffmann, Raphael | |
| 700 | 1 | _aShen, Jin-Song | |
| 700 | 1 | _aVakhrushev, Sergey Y | |
| 700 | 1 | _aClausen, Henrik | |
| 700 | 1 | _aYang, Zhang | |
| 773 | 0 |
_tNature communications _gvol. 10 _gno. 1 _gp. 1785 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41467-019-09809-3 _zAvailable from publisher's website |
| 999 |
_c29642736 _d29642736 |
||